Ozempic

• Weight-loss medication helps mom manage her obesity. Quebec won’t pay for any of it

  Quebec's health insurance board currently doesn't cover Ozempic and similar weight-loss medication unless they are prescribed for patients who are diagnosed with diabetes.

  Canada

  Oct 24
  
• Can semaglutide help reduce opioid overdoses? What new study suggests

  Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

  Health

  Sep 26
  
• Advertisement
• Ozempic maker says unapproved compounded drugs being sold in Canada

  Novo Nordisk says it has filed a complaint with Health Canada regarding the promotion and sale of compounded semaglutide – a key ingredient in both Ozempic and Wegovy.

  Health

  Jul 30
• Advertisement
• Ozempic, Wegovy use may be linked to ‘eye stroke’ and blindness, study finds

  The use of semaglutide drugs, like Wegovy and Ozempic, may have an increased risk of sudden and irreversible vision loss and blindness, the study found.

  Health

  Jul 4
• No reports of counterfeit Ozempic in Canada amid WHO warning

  Health Canada says it has not received any reports of counterfeit Ozempic in the country after the WHO issued a warning about fake batches in some countries.

  Health

  Jun 21
• Nestle to target American Ozempic, Wegovy users with US$5 pizzas

  Nestle will market a new, US$5 line of frozen pizzas and protein-enriched pastas in the U.S., which it says it designed specifically for people taking Wegovy or Ozempic.

  Consumer

  May 21
• Wegovy now in Canada: Who should (and shouldn’t) use the weight-loss drug

  After years of persistent shortages, Canadians can now access Wegovy, an on-label weight loss medication, made by the same manufacturers of Ozempic.

  Health

  May 6
• Wegovy set to launch in Canada. What to know about the weight-loss drug

  Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.

  Health

  May 2
• Advertisement
• Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition

  The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.

  Health

  Apr 30
• Advertisement
• EU probe of Ozempic, Wegovy ends with no evidence of link to suicide

  The European Medicines Agency regulatory committee announced the results of its review on Friday, the latest group to find no known tie between drugs like Ozempic and suicide.

  Health

  Apr 12